ReviewMolecular cancer2024

Efficacy and safety of bispecific antibodies vs. immune checkpoint blockade combination therapy in cancer: a real-world comparison.

Linyan Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.